Credit: Afrigen Biologics
Many steps remain before Afrigen’s mRNA vaccine candidate can be distributed to people in Africa and beyond, and it definitely won’t help to curb the pandemic this year. But the WHO hopes that the process of creating it will lay the foundation for a more globally distributed mRNA-vaccine industry. Patrick Arbuthnot, director of gene-therapy research at the University of the Witwatersrand, says, “We were not intimidated, because mRNA synthesis is a fairly generic procedure.” Despite delays in the shipment of raw materials, the team completed this process in ten weeks and sent vials of mRNA to Afrigen in early December.
There are less infections in SA compared to rich countries per reports, right?
Of course they go to the richest countries. The richest countries are the ones with the labs and the money. How else do we encourage research and who will provide the funds besides investors with the capital to do so? Do you know what motivates people?
lies.
as long as mRNA is what is is - very limited in neutralizing future variants, decreasing in its efficacy in too short a time, causing serious side effects!🤔 - I don’t bet on it. I rely on a whole-virion vax detecting ALL variants WITHOUT any severe side effects IchooseCOVAXIN
But Moderna don’t work MRNA garbage vaccines are not working against variants therefore traditionally made vaccines like covaxin is the answer.
Good for Africa and great for SouthAfrica